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Summary: Keratan sulfate was found to be present in all Segments of human aortae of different age.
The total glycosaminoglycan content decreases from 18.2 in the 2nd to 14.2 μιηοΐ hexosamine per g dry weight in
the 8th decade. This decrease becomes more pronounced, if the inorganic material (calcium phosphate), the propor-
tion of which increases from 10 g/kg (2nd) to 140 g/kg (8th), is included in the dry weights; the total glycosamino-
glycan content, then decreases from 18.0 in the 2nd to 12.4 μιηοΐ per g dry weight in the 8th decade.
The glycosaminoglycans in human aortae between the 2nd and the 8th decade of age consist chiefly of chondroitin
4-sulfate (20-30%), chondroitin 6-sulfate (20-29%) and heparan sulfate (18-27%), followed by dermatan sulfate
(13-17%), hyaluronate (5-15%), keratan sulfate (4-8%) and chondroitin (1-3%).
The concentrations of chondroitin 6-sulfate and heparan sulfate decrease from the 2nd to the 8th decade, whereas the
concentration and relative proportion of keratan sulfate increase especially from the 6th to the 8th decade.
With regard t the longitudinal distributions of the glycosaminoglycans in human aortae the 4th and the 8th decade
of age were studied. The total glycosaminoglycan concentration of the younger group exhibits an increase from
proximal to distal regions, whereas in the older group the glycosaminoglycan concentration remains nearly constant
in all Segments, beirig higher in the aortic arch and lower in the two distal regions than in the corresponding regions
of younger aortae.
In the region of the aortic arch the concentration and the relative proportion of hyaluronate, dermatan sulfate and
chondroitin 4-sulfat decrease on ageing, whereas those of heparan sulfate, keratan sulfate and chondroitin 6-sulfate
increase. In the middle region of human aortae only keratan sulfate and chondroitin 4^sulfate increase with age. In the
region of the bifurcatio, where the highest deposition of inorganic material has been found, Contents and relative
proportions of hyaluronate, Jceratan sulfate and dermatan sulfate iiicrease during ageing, whereas those of heparan
sulfate and the chondroitin sulfates, especially chondroitin 6-sulfate, decrease.
Topographische und altersabh ngige Verteilung der Glykosaminoglykane in der Aorta des Menschen
Zusammenfassung: Kerat nsulfat wurde in allen Abschnitten der Aorta des Menschen gefunden.
Der Gesamtgehalt der Glykosaminoglykane nimmt von 18,2 μτηοΐ/g Trockengewicht in der 2. Altersdekade auf 14,2
in der 8. ab. Diese Abnahme ist noch st rker ausgepr gt, wenn die mineralischen R ckst nde (Calciumphosphat), de-
ren Anteil von 10 g/kg im 2. auf 140 g/kg im 8. Jahrzehnt ansteigt, in das Trockengewicht einbezogen werden; der
Glykosaminoglykaii-Ges mtgehalt sinkt dann von 18,0 in der 2. auf 12,4 μηιοΐ/g Trockengewicht in der 8. Lebens-
dekade.
Die Hauptanteile der Aorta-Glykosaminoglykane zwischen dem 2. und 8. Lebensjahrzehnt bilden Chondroitin-4-sulfat
(20-30%), Chondroitin-6-sulf t (20-29%) und Heparansulfat (18-27%), gefolgt von Dermatansulfat (13-17%),
Hyaluronat (5-15%), Keratansulfat (4-8%) und Chondroitin (1-3%).
Die Konzentrationen von Chondroitin-6-sulf t und Heparansulfat nehmen von der 2. zur 8. Dekade ab, wogegen
Keratansulfatgehalt und -anteil besonders vom 6. zum 8. Lebensjahrzehnt zunehmen.
Hinsichtlich des longitudinalen Verteilungsmusters der Glykosaminoglykane in der humanen Aorta wurden das 4.
und 8. Lebensjahrzehnt untersucht. Hiernach zeigt die j ngere Gruppe einen Anstieg der Glykosaminoglykan-Ge-
samtkonzentration von proximal nach distal, die der lteren Gruppe hingegen bleibt in allen Segmenten nahezu konstant,
wobei der Glykosaminoglykangehalt im Aortenbogen-Abschnitt h her, in den beiden distalen Segmenten niedriger
als in den entsprechenden Abschnitten der j ngeren Aorten ist.
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Im Aortenbogen nehmen mit zunehmendem Alter Konzentration und relativer Anteil von Hyaluronat, Dermatan-
sulfat und Chondroitin-4-sulfat ab, von Heparansulfat, Keratansulfat und Chondroitin-6-sulfat jedoch zu. Im mittle-
ren Aortenabschnitt ist nur eine Zunahme des Keratansulfat- und Chondroitin-4-sulfat-Gehältes festzustellen. Im
Bifurcatio-Abschnitt, wo der höchste Gehalt an mineralischen Ablagerungen gefunden wurde, steigen die Gehalte
und relativen Anteile von Hyaluronat, Keratansulfat und Dermatansulfat an, während diejenigen von Heparansulfat
und den Chondroitinsulfaten, insbesondere von Chondroitin-6-sulfät, abnehmen. ' f
Introduction
The mean thickness of the blood vessel wall is doubled
from the 20th to the 70th year of age. An increase in the
collagen content is predominantly responsible for this
change, in addition to changes in the ground substance.
Furthermore, the mean thickness of collagen fibrils in
the human aorta increases with ageing, äs does the
degree of crosslinking of collagen and elastin (1), whereas
cell density and activity of the enzymes in energy metab-
olism decrease with age. Several groups have determined
the change in glycosaminoglycan content in human aqrtic
tissue with ageing. Kaplan & Meyer (2) äs well äs Böttcher
& Klynstra (3) were not able to establish a significant
age-dependent alteration of the total glycosaminoglycan
content. It has been shown that the proportion of
hyaluronate to chondroitin sulfates decreases with age
(2,4, 5). Buddecke (6), however, found an increase of
hexosamine, especially of glucosamine. According to
Clausen (7) the uronic acid content of the aorta de-
creases with age, whereas Krüger & Teller (8) established
an increase of the uronic acid content. Recently Toledo
&Mourao (9) showed that the chondroitin 6-/4-sulfate
ratio in the intima + media layers of human aortae
increases with age.
On account of these contradictory results we took up
again the question of age-dependent changes of the
aortic glycosaminoglycans using a specially adapted
method that prevents any loss of glycosaminoglycan
during the Isolation procedure.
This was especially important with regard to keratan
sulfate, the existence of which in human aortic tissue
had been postulated but not cleariy identified by
Buddecke (6). Some years ago we isolated and character-
ized keratan sulfate from human aorta (10—12). Since
keratan sulfate could play an important role in the
pathogenesis of atherosclerosis, it became another task
of the present study to investigate the distribution of
keratan sulfate in human aortic Segments of different
age.
The results of Toledo & Mourao concerning the distribu-
tion of glycosaminoglycans in the different aortic wall
layers demonstrate that the glycosaminoglycan con-
centration decreases continuously from the intima to
the adventitia (9). In the same direction they found an
•increase in the proportion of dermatan sulfate, but an
decrease in that of heparan sulfate. Murata et al. (13),
however, reported an increase of dermatan sulfate and
heparan sulfate. Little is knöwn about the age-depend-
ent glycosaminoglycan distribution pattern along the
human aorta. Manley &Hawsksworth (14) published
an observation concerning the distrümtiön of hyaluron-
ate, heparan sulfate and chondroitin sulfate in the
ascending, the thoracic and abdominal aorta of a man
of 29. Recently, Montani et al. (15—17) studied the
distribution of glycosaminoglycans äs a functipn of age
and of the number of atherosclerotic lesions in the
human aortic arch and abdominal aörtä, but the
methods applied by these authörs did riöt seern suitable
for producing reliable results. Thus, it became the third
töpic of the present study to determine the topographic




Cryst. papain was obtained from Sigma, München; ABGlyase
(EC 4.2.2.4), AC-iyase (EC 4.2.2.5), chondro-4-(EC 3.1.6.9)
and chondro-6-sulfätase (EC 3.1.6.10) were from Miles, Frank-
furt; galactose dehydrogeriäse was pürchased from Boehringef,
Mannheim. Dowex 1X2 (200-400 mesh) was from Serva, Hei-
delberg; -Gel P-2 was obtained from Bio-Rad Laboratories,
München; Sephadex CM 00 was pürchased from Pharmacia,
Frankfurt. The cellulose sheets (20 X 2vO cm) used were from
Merck, Darmstadt. The Standard glycosaminoglycans used were
highly purified and charaeterized prepärations from human liver
and pig skin (dermatan sulfate), bovine tracheal cartilage (chon-
droitin 4^ and 6^sulfate, sepaiated on a cellulose^columh in
calcium acetate/ethanol at different ethanpl concentrations),
from bovine vitreous humour (hyaluronate), bovine cornea and
tracheal cartilage (keratan sulfate), from human and bovine
liver (heparan sulfate).
All other chemicals used were of p.a. qüality Standard,
Human aortae
The aortae were obtained immediately after section within 12
to 20 hours post mörtem. None of the patients suffered from
diabetes mellitus or more than age-related hypertonus, hypo-
thyreosis, disordered lipid metabolism, or, despite athero-.
sclerotic lesions, from an aortic disorder, e.g. mesaortitis
syphilitica.
Aortae from 4 age-groups were collected: one aorta from the
second decade of age (13 years), 5 aortae each from the 4th
decade (31-38 years), 6th decade (52-59 years) and 8th
decade (69-76 years). After removal of the adventitia, the
aortae of the 4th and 8th decade were divided intp three seg-
ments,
segment A corresponding to the aortic arch and the aorta
descendens tp the regicm a little äbove the truncus coeliacus,
segment B from there to just below the arteria mesenterica
inferior, and
segment C from this region to the bifurcatio aortae including
the proximal 3-5 cm of the arteriae iliäcae?cömmunes.
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From each segment a 3-5 mm segment was taken for histologi-
cal examination. All aortae were kept at 4 °C in absolute
ethanol until processed.
The aortae were cut into small pieces (2-3 mm) and then
powdered in an electric mill under liquid nitrogen. For Upid
extraction the powder was suspended in acetone (10 g powder
in 150 ml acetone), stirred for 12 hours, filtered, washed
three-times with acetone, dried at 50 °C and the dry weight
determined.
Isolation and Separation of the aortic glycosaminoglycans
Aliquots of the powdered tissue from total aortae of all age
groups äs well äs from the Segments A, B and C of the fourth
and eighth decade of age were digested twice with cryst. papain
(0.5 mg/g dry tissue) at 60 °C for a total of 72 hours in sodium
acetate buffer pH 6.8 (0.10 mol/1 sodium acetate, 0.005 mol/1
ethylenediaminetetraacetate, disodium sah, 0.005 mol/1 cysteine
hydrochloride) at a concentration of 3 g tissue in 100 ml buffer.
After 36 hours another portion of papain and cysteine hydro-
chloride was added. The mixture was filtered, the crystalline
residue washed three-times with acetone, dried and weighed. By
infrared spectroscopy these residues were shown to be primarily
calcium phosphates. All values given in this study are related to
the dried tissues minus the inorganic residues. The filtered
proteolysate was acidified to pH 1.3 with HC1, the precipitates
fornied were separated by centrifugation and discarded, the
supernatant neutralized with NaOH and concentrated to one
tenth of volume.
Desalting was performed on Bio^Gel P-2 columns (2 X 90 cm)
equilibrated and eluted with ethanol/water (volumes, 100 +
900 ml) and 5 ml portions were collected. The glycosamino-
glycans were monitored by uronic acid determinations and the
salts by conductivity measurements. The glycosaminoglycan-
containing portions were pooled and concentrated to 10 ml.
For the evaluation of optimal Separation conditions of the
aortic glycosaminoglycans by chromatography on Dowex 1 X 2 ,
an aliquot of the desalted glycosaminöglycan mixture from
aortae of the sixth decade was loaded onto a Dowex 1 X 2
column (2 X 20 cm) equilibrated with 0.15 mol/1 NaCl. Elution
was performed with 3 bed^volumes each of stepwise increasing
NaCl eoncentrations: 0.15-0.25-0.50-0.75-1.0-1.25-1.5-
1.75-2.0-3.0 mol/1. Each fraction was concentrated, desalted
by gel filtration on Bio Gel P-2, and analysed for the glycos-
aminöglycan types.
As a result of the foregoing chromatography on Dowex 1 X 2
the Separation procedure could be shortened to an elution




3.0 mol/1 (fraction IV).
All glycosamiripglycan mixtures from total aprtae or from
Segments A, S and C of different age are fractionated on Dowex
1 X 2 columris (2 X 20 cm) by elution with three bed-volumes
each of these four NaCl-solutions. The desalted fractions II, III
and IV were then analyzed for their glycosaminöglycan types
and constituents. get fuitlier Information about the com-
position of the aortic keratan sulfate fräetfons an aliquot of
"fraction IV (3.0 mol/1 NaCl) of the eighth decade (69-76 years)
was chromatographed on a Sephadex G-100 column (1.5 X
150 cm) eluted with 1ÖÖ ml/l ethanol. The elution profile is
shown in figure 2. Four subfractions IV-1, IV-2, IV-3 and IV4
were obtained, the data of the main constituents of which are
listedintable 1.
Thin-layer chromatography of the aortic glycosamino-
glycans
TLC on celluiose sheets (20 X 20 cm) of the calcium salts of
the glycosaminoglycans were performed according to Humbel
& Chamoles (18); This technique was also extended to the
barium salts of the glycosaminöglycan mixtures. The spots (not
stained) of aortic keratan sulfate and heparan sulfate positions
from every age group were scraped off and the celluiose powder
extracted with water (3 X 0.5 ml). After evaporation to dryness,
re-sölubilization with water and hydrolysis in 3 mol/1 HC1 at
105 °C for 15 hours, glucosamine was determined in the arriino
acid analyzer.
Analysis of the aortic glycosaminöglycan types
Hyaluronate was determined by degradation with hyaluronate
lyase (EC 4.2.2.1) according to Greiling (19) with the following
modification: after incubation 3 volumes of sodium acetate-
saturated ethanol were added, the mixture was centrifuged, the
supernatant evaporated to dryness, re-solubilized in l ml H2O,
hydrolysed in 3 mol/1 HC1 at 105 °C for 15 hours and the
glucosamine content determined in the amino acid analyzer.
Chondroitin (= very low sulfated chondroitin sulfate) was deter-
mined äs galactosamine in fraction II (0.5 mol/1 NaCl) after
chondroitin ABC-lyase treatment (20) followed by precipita-
tion with 3 volumes of sodium acetate-saturated ethanol, centrifu-
gation, evaporation of the supernatant to dryness, re-solubiliza-
tion in water, hydrolysis in 3 mol/1 HC1 at 105 °C for 15 hours
and galactosamine determination in the amino acid analyzer.
To ascertain the chondroitin 4-sulfate, chondroitin 6-sulfate
and dermatan sulfate Contents, degradation with chondroitin
AC-lyase (EC 4.2.2.5), chondroitin ABC-lyase (EC 4.2.2.4) in
combination with chondro-4- and chpndro-6-sulfatase
(EC 3.1.6.9 and EC 3.1.6.10, resp.) was used (20).
Heparan sulfate in fractions II, III and IV was estimated after
degradation with nitrous acid (21) followed by precipitation
with 3 volumes of sodium acetate-saturated ethanol, centrifuga-
tion, re-solubilization of the precipitate, hydrolysis in 3 mol/1
HCl at 105 ° C for 15 hours and glucosamine determination by
means of an amino acid analyzer. An aliquot of the re-solubilized
precipitate was subjected to TLC on celluiose sheets in the
barium acetate System. Spots (not stained) remaining at the
Start and containing dermatan sulfate and heparan sulfate were
scraped off, the celluiose powder extracted with water (3 X
0.5 ml) and the extract estimated for glucosamine after
hydrolysis in 3 rnol/1 HC1. The difference in glucosamine values
before and after degradation with ? plus the glucosamine
value remaining at the Start in TLC was taken äs the value for
heparan sulfate.
Analyses of the aortic glycosaminöglycan constituents
Urönic acid was determined using the carbazole reaction of
Dische (22) äs modified by Bitter & Muir (23), büt in a fully
mechanized Version (24) which permits 40 determinations per
hour down to a concentratioft of 10 / . The galactose con-
tent was measuired enzymatically with galactose dehydrogenase
(25) after hydrolysis in l mol/1 HCl for 3 hours at 105 °C.
Sulfate was determined turbidimetrically äs BaSO4 (26) after
hydrolysis in l mol/1 HCl for 3 hours at 105 °C Glucosamine
and galactosamine, together with amino acids, were determined
after hydrolysis for 15 hours in 3 mol/1 HCl at 105 °C using an
amino acid analyzer (27). The elution program of the analyzer
was modified to allo w the determination of glucosamine and
galactosamine (positioned between the amino acids phenyl-
aianine and lysine) and the other amino acids in less than
2V| hours down to the 100 pmol ränge. Quantitative iduronic-
glucuronic acid Separation was performed according to 1. c. (40).
Results
Isolation and characterization of keratan sulfate in
human aortic Segments ofdifferent age
In preliminary experiments to differentiate the glycos-
aminoglycans of human aortae from different age groups
the presence of glucosamine-containing glycosamino-
glycans was shown in fractions eluted from Dowex 1X2
columns with 3 mol/l NaCl solution. As heparan Sulfates,
even those with high degrees of sulfation, are eluted
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from Dowex l X 2 with lower NaCl concentrations (at
most l .75 mol/1), the suspicion became strong that the
glucosamine content in the 3 mol/1 NaCl-fraction might
be attributable to keratan sulfate.
To evaluate the optimal conditions for separating
heparan Sulfates from keratan sulfate by Dowex 1X2
chromatography, aortic glycosaminoglycans of the sixth
decade of age were separated into several fractions by
elution with stepwise increasing concentratioris of NaCl.
Analyses of the fractions were performed by TLC on
cellulose sheets s the calcium and s the barium salts,
by glucosamine and galactosamine determinati ns, by
enzymic methods using hyaluronate lyase, chondroitin
AC-lyase and ABC-lyase, and by degradation with HNO2.
Hyaluronate could be detected only in the fraction
eluted with 0.5 mol/1 NaCl together with small amounts
of very low sulfated chondroitin Sulfates (chondroitin).
The chondroitin Sulfates and dermatan sulfate were
found in all fractions eluted with 0.75 mol/1 NaCl up to
3.0 mol/1 (fig. l,,i;esults of the fraction 0.75 mol/1 NaCl
not shown), whereas heparan sulfate and keratan sulfate
exhibited a relatively clear-cut Separation from each
other. The overlapping fractions of these two glycos-
aminoglycans were eluted with 1.5 and 1.75 mol/1 NaCl
(fig. 1), but the heparan sulfate in fraction 1.75 mol/1
NaCl represented less than 5% of total heparan sulfate,
and the keratan sulfate in fraction l .5 mol/1 NaCl made
up less than 10% of total keratan sulfate. Since more
than 90% of total keratan sulfate was found in the frac-
tions eluted with 1.75, 2.0 and 3.0 mol/1 NaCl and more
than 95% of total heparan sulfate in the fractions eluted
with 1.0, 1.25 and 1.5 mol/1 NaCl, the elution program
for estimating the glycosaminoglycan distribution along
the aortae of different age-groups was simplified by
choosing only four concentrations of NaCl: 0.15 (frac-
tion I), 0.5 (fraction II), 1.5 (fraction III) and 3.0 mol/1
(fraction IV), whereby the glucosamine in fraction II
(0.5 mol/1 NaCl) represented hyaluronate, that in frac-
tion III (1.5 mol/1 NaCl) heparaji sulfate, and that in
fraction IV'(3.0 mol/1 NaCl) keratan siiifate.
All fractions, II, III and IV, were monitored by TLC in
calcium and barium acetate Systems before and aftef
degradation with chondroitin ABC4y se. TLC of the
glycosaminoglycans in bpth Systems has the advantage
of ittutual control, since in the barium acetate System
heparan sulfate and dermatan sulfate remain at the
origin, whereas in the calcium acetate System >this is tiiie
only for dermatan sulfate.
Though the results of TLC proved the presence of kera*
tan sulfate in all human aortic Segments of different age,
an addition l attempt was made to get more Information
about the constit ents of the keratan sulfate fractions.
For this purpose, an aliquot f the fraction IV (3.0 mol/1
NaCl) of the eight decade (69—76 years) was frac-
tionated further by gel chromatography qn Sephadex
G-100 (fig. 2). Fo r subfraetions IV-1, IV-2, IV-3 aftd
IV-4 were obtained and analyzed for glucosaitiine,
galactosamine, uronic acid and sulfate (tab. 1). In none
of the subfractions could keratan sulfate be completely
separated from chondroitin sulfate and dermatan sulfate,
though the keratan sulfate content was lowest in subfrac--
tion IV-1 (28%) and highest in IV-3 (55%) s shown by
the glucosan ne/galactosarnine ratio (tab. 1). In all frae-
tions the glucosamine content corresponded well with
the galactose content, and the galactosarnine content
corresponded well with the uronic acid eontent. All
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Fig. 1. TLC chromatography according to I.e. (16) of the aortic glycosaminoglycans eluted 'by different NaCl concentrations from
Dowex 1 X 2 columns in the calcium acetate/ethanol System (Ca Ac^) and barium acetate/ethanol System (Ba Ac2> before (B)
and after (A) digestion with chondroitin ABC-lyase. HS = heparan sulfate (human liver); KS-C = ker tan sulfate (bovine
cornea); KS-T = keratan sulfate (bovine tracheal cartilage); C4S =? chondroitin 4^sulfate (bovine trache l cartilage);
C6S = chondroitin 6-sulfate (bovine tracheal cartilage); DS = dermatan sulfate (porcine skin). v *
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Fig. 2. Sephadex G-100 chromatography of the keratan sulfate-
containing Dowex 1X2 fraction eluted with 3 mol/1
NaQ from aortae of the 8th decade (69—76 years).
Further details in material and methods. Analyses of
the subfraction IV- 1, IV-2, IV-3 and IV-4 are listed in
table 1.
Tab. 1. Analytical data [μηιοΐ/fraction] of fraction IV and its
subfractions from age-group 69-76 years. The four sub-
fractions were obtained by chromatography of fraction
IV on Sephadex G-100 eluted with 100 ml/l ethanol.
IV IV-1 IV-2 IV-3
Glucosamine 5.7 0.75 2.7 2.1
Galactose 6.1 0.70 2.7 2.4
Galactosamine 7.3 2.0 3.4 1.7
Uronicacid 7.1 2.1 3.2 1.7
Sulfate 19.3 4.0 9.7 5.1
GluCOSamine 0-70 Λ Ο Τ n ΤΩ 1 ~>A0.78 0.37 0.79 1.24
Galactosamine









Age-dependent distribution ofthe glycosaminoglycans
in the human aorta
The age-related decrease in glycosaminoglycan content
of the human aorta (tab. 2) from 18.2 in the 2nd decade
to 14.2 Miriol hexosamiiie per g dry weight in the 8th
decade d es not seem very prpnounced, though ne
must keep in mind that the content of iriorganic materials
was not included in the dry weights. These inorganic
residues, which were shown by infrared analyses to be
predominantly calcium phosphate, amo nted to less
than 1% in the 2nd decade, nearly 9% in the 4th, about
•
Tab. 2. Total glycosaminoglycan content and its 'distribution in
Dowex fraptipns II, III and IV (eluted with 0.5, 1.5 and
3.0 mol/1 NaCl resp.) from human aortae of different
age given by their hexosamine values [/urjnol/g dry weight].
Age group Total Total hexosamine
(a) hexosamine in fractions
n in
13 18.2 1.8 13.0
31-38 15.3 2.1 10.2
52-59 15.1 1.0 11.5






1 \% in the 6th and more than 14% in the 8th decade of
age. With regard to the aortic segments, the highest
values for inorganic residues were found in the region
ofthe bifurcatio aortae, e.g. 25% in segment C ofthe
8th decade.
The decrease in total hexosamine content with age is
also found in fractions III and IV (tab. 2), in which the
chondroitin Sulfates, dermatan Sulfate, heparan Sulfate
and keratan sulfate appeared.
Table 3 shows especially the Situation in fractions IV,
where the content of the galactosaminoglycans decreases
continuously with age, and the keratan sulfate concentra-
tion remains constant up to the sixth decade before
increasingup to the 8th decade by 50%. The degree of
sulfatation, expressed s sulfate/hexosamine ratio,
behaves in a similar manner (tab. 3). Glucosamine/
galactose and galactosamine/uronic acid ratios are near
to unity in fractions IV of all age-groups.
The concentrations and relative proportipns of the differ-
ent glycosaminoglycan types in the aortae between the
2nd and 8th decade of age are shown in table 4. The
main fractions are represented by chondroitin 4-sulfate
^
Tab. 3. Analytical data [μπιοΐ/g dry weight] of the glycosamino-
glycans from human aortae of different age groups in
fractions IV eluted from Dowex 1X2 columns with
3 mol/1 NaCL
Glucosamine, galactosamine, uronic acid and sulfate
were estimated s described in methods.
Age group
13a 31-38a 52-59a 69-76a
Glucosamine 0.8 0.7 0.8 1.2
Galactosamine 2.6 2.3 1.8 1.4
Uronicacid 2.4 2.1 1.7 1.5
Galactose 0.9 0.9 1.0 1.3
Sulfate 4.5 3.8 3.5 4.0
— ate 130 1-9 135 119Hexosamine
Tab. 4. Distribution of the different glycosaminoglycans from
human aortae of different age. Data given in jumol/g dry
weight. Data in brackets: mol/1 00 mol of total glycos-
aminoglycans.
Ch ^ very low sulfated chondroitin sulfate;
C4S= chondroitin 4-sulfate;
C6S^ chondroitin 6-sulfate;
DS = dermatan sulfate;
HS = heparan sulfate;
KS = keratan sulfate;
HA = hyaluronate
Age group
13a 31-38a 52-59a 69-76a
Ch 0 (0) 0.3 (2.0) 0.2 (1.3) 0.4 (2.8)
C4S 3.8 (20.9) 3.1 (20.3) 4.6 (30.5) 3.0 (21.1)
C6S 4.6 (25.3) 4.4 (28.7) 3:1 (20.5) 3.0 (21 .'2)
DS 2.3 (12.6) 2.0 (13.1) 2.6 (17.2) 1.9 (13.4)
HS 4.9 (26.9) 3.1 (20.3) 3.0 (19.9) 2.6 (18.3)
KS 0.8 (4.4) 0.7 (4.6) 0.8 (5.3) 1.2 (8.4)
HA 1.8 (9.9) 1.7 (11.0) 0.8 (5.3) 2.1 (14.8)
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(20-30%) chondroitin 6-sulfate (20-29%) and heparan
sulfate (18-27%) in these age-groups, followed by
dermatan sulfate (13-17%), hyaluronate (5-15%) and
keratan sulfate (4-8%). The fraction named chondroitin
is a very low sulfated chondroitin sulfate eluted in frac-
tion II together with hyaluronate. It accounts for 1-3%
of the total glycosaminoglycans and was digested by
chondroitin AC- and ABC-lyases. Enzymatic degradation
of fractions III and IV by chondroitin AC- and ABC-lyase
showed that only traces of 2-acetamido-2-deoxy-3-O-
(|3-£)-gluco-4-enpyranosylurons ure)-/)-galactosewere
berated from chondroitin 4-sulfate, chondroitin 6-
sulfate and dermatan sulfate. These results match the
liigh degree of sulfatation found in fractions IV from
the different age-groups (tab. 3).
The concentration of chondroitin 6-sulfate decreases
from the 2nd t o the 8th decade, whereas the contents
of chondroitin 4-sulfate and dermatan sulfate show no
tendency to increase or decrease. The relative proportion
of chondroitin 6-sulfate seems to be diminished between
the 4th and 6th decade (tab. 4). A similar decrease in
the relative proportion of heparan sulfate is found
between the 2nd and the 4th decade. The keratan sulfate
concentration increases between the two last age-groups,
but the percentage of keratan sulfate shows a tendency
to increase in all age-groups, the increase being only
20% from the 2nd to the 6th decade, and nearly 60%
from the 6th to the 8th decade (tab. 4).
Topographie changes ofthe glycosaminoglycan distribu^
tion along the aortae with age
Since results of the longitudinal distribution of the gly-
cosaminoglycans in human aortae of different age are in-
complete, we tried to obtain further data from three
aortic Segments of similar size: the aortic arch (segment
A), the region at the origin of the arteriae renales
(segment B) and the bifurcatio aortae (segment C), with
regard to the 4th and the 8th decade of age. As can be
seen from table 5, the total glycosaminoglycan con-
centration of the younger group increases from proximal
to distal regions especially from segment A to B, whereas
in the older group the total glycosaminoglycan con-
centration remains nearly constant in all Segments, being
lower in B and C, and higher in A than the corresponding
ones of the younger aorta. The glucosaminbglycans
showed their highest concentration in the region of the
bifurcatio (C) in both age groups, and the galactosamino-
glycan contents decreased in the two distal Segments
with age.
The concentration of hyaluronate increases from prox-
imal to distal in both age groups especially in the older.
The relative proportion of hyaluronate to total glycos-
aminoglycan seems to remain constant along the aorta
in the younger age-group, but to increase significantly
in the older. During ageing, the cpntent of hyaluronate
s well s its relative proportion decrease in segment A
and increase in segment C.
Tab. 5. Topographie distribution [μηιοΐ/g dry weightj of the
glycosaminoglycans from aortae of different age. Data
in brackets: mol/100 mol of total glycosaminoglycans
in the aortic segment.
A = arcus aortae
B = aorta at the origin of the arteriae renales

































































While heparan sulfate, expressed s μτηοΐ/g dry weight
arid mol/100 mol total glycosaminoglycan, incre ses
from the aortie arch to the bifurcatio in the younger
aorta, the reverse is the case in the older aorta. This
means, with regard to ageing, that the heparan sulfate
increases in the region of the arcus aprtae, while decreas-
ing iri the middle region and even more so in the
region of the bifurcatio.
The keratan sulfate content (μιηοΐ/g dry weight) in-
creases from proximal to distal by 100% in the youiiger
and the older aorta. This increase is less prpnounced in
terms of its relative prop rtion (mol/100 mol total
glycosaminoglycan) espeeially in the yo nger aorta. An
age-related increase in the concentration (μηιοΐ/g dry
weight) and the relative proportion (mol/100 mol total
glycosaminoglycan) of keratan sulfate can be observed
in all segments of the aorta.
Dermatan sulfate does not show pronounced differences
in its concentration and relative proportion along the
aorta. With age there seems t o be a deerease in the region
ofthe aortic arch and perhaps 'in the middle segment,
and an increase in the region of the bifurcatio.
The ratio of the two chondroitin Sulfates is nearly
unity in the region ofthe aortic arch from the yo nger
group, but in the older this ratio is shifted in favour of
chondroitin 6-sulfate. The latter Situation is also found
in segments B and C of the younger group, the reverse
being the c se in segment B of the older group, whereas
the chondroitin 4rsulfate/chondroitin 6-sulfate ratio is
nearly unity in the region of the bif reatio.
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In summarizing the changes of the cüfferent glycosamino-
glycan types in the three aortic segments, it can be
established that in the region of the aortic arch (segment
A) the concentration (/imol/g dry weight) and the rela-
tive proportion (mol/100 mol total glycosaminoglycan)
of hyaluronate, dermatan sulfate and chondroitin
4-sulfate decrease on ageing, whereas those of heparan
sulfate, keratan sulfate and chondroitin 6-sulfate exhibit
an age-related increase. In the region at the origin of the
arteriae renales (segment B), only keratan sulfate and
chondroitin sulfate show an increase in content and
relative proportion with age, while the other glycos-
aminoglycans decrease. The concentrations ( /g dry
weight) and relative proportions (mol/100 mol total
glycosaminoglycan) of hyaluronate, keratan sulfate and
dermatan sulfate in the region of the bifurcatio aortae
increase during ageing, whereas those of heparan sulfate
and the chondroitin Sulfates decrease. These changes
are most pronounced for hyaluronate, keratan sulfate,
heparan sulfate and chondroitin o^sulfate, especially in
the aortic segment with the highest deposition of in-
organic material.
Discussion
According to our results the total glycosaminoglycan
content of the intimal plus medial layer of human äortae
decreases with increasing age. This finding is in agree-
ment with that ofClausen (7) whp stated a decrease of
the uronic acid content of the aorta on ageing, whereas
Krüger & Teller (8) found an increase of this glycos-
aminoglycan constituent. With regard to our results one
must consider that the decrease of the total glycos-
aminoglycan content betweeii the 2nd (18.2
hexosamine per g dry weight) and the 8th decade
(14.2 /g dry weight) becomes more distinct when
the mineral residues are iiiclüded in the dry weights; in
this cäse there would be ä decrease from 18.0 to
12.4 /g dry weight. The residues were shown by
infrared analysis tö consist nearly completely of cal-
cium phosphate. Their contents inerease frorn the aortic
arch (segment A) to the bifurcatio aortae (segment C)
in eaeh age group. Possibly, this may be an expression
öf the number of atherösclerotic lesions, an increase of
which in the abdominal aorta was found by Montani et
al. (17). Thus, the rninerai residues in the aorta of the
8th decade which average 14% öf dry weight, reach
about 25% in the region pf the bifurcatio.
The relative proportions of the differerit aortic glycos-
aminoglycan types in all age groups amount to 20—30%
chondroitin 4-sulfate, 20-29% chondroitin 6-sulfate,
18-27% heparan sulfate, 13—17% dermatan sulfate,
5-15% hyaluronate, 4-8% keratan sulfate and 1-3%
chondroitin. The fraction named chondroitin is an
extremely low sulfated chondroitin sulfate which could
be degraded by chondroitin AC- and ABC-lyase. The
enzymic degradation of the fractions containing the
chondroitin Sulfates and dermatan sulfate by chondroi-
tin AC- and ABC-lyase resulted in only traces of un-
sulfäted and unsaturated disaccharides. This agrees with
the high sulfate contents of the glycosaminoglycans,
especially those in fraction IV, the sulfatation degree of
which was found to be between l .3 and l .5.
In the total aorta the content of chondroitin 6-sulfate
seems to decrease from the 2nd to the 8th decade,
whereas the concentrations of chondroitin 4-sulfate
and dermatan sulfate show no tendency to decrease or
increase. Recently, Toledo &Mourao (9) found in the
intimal + medial layer of human aortae chondroitin
6-sulfate/chondroitin 4-sulfate-ratios of 2—3 independ-
ent of age; in atheromata these ratios were äs high äs
4—6. We are not able to confirm their results, äs we found
chondroitin 6-sulfate/chondroitin 4-sulfate-ratios of only
l .2 in the 2nd, l .4 in the 4th, 0.7 in the 6th and l .0 in
the 8th decade of age. Assuming that the number of
atherösclerotic lesions in the human aortae studied by
us increase on ageing, the chondroitin 6-sulfate/chon-
droitin 4-sulfate-ratios would have to increase with age
to values above 2 according to Toledo &Mourao (9).
This, however, is not the case; ratrjier we found a
decrease of the ratio with age. Thus, our results do not
support the Suggestion of Toledo &Mourao (9) that a
relative increase of chondroitin 6-sulfate in human
aortic tissue of adülts and in atherosclerosis reflects
structural and metabolic modifications, which — äs
chondroitin 4-sulfate, but not chondroitin 6-sulfate, is
capable of inhibiting the formation of complexes
between LDL and highly sulfated glycosaminoglycans
(28) — favour the deposition and accumulation of lipo-
proteins within the connective tissue framework of the
aortic wall.
Investigation of the tqpographic distribution of the
different glycosaminoglycan types along the aorta of
the 4th and 8th decade, provides more detailed Informa-
tion. In the yoünger aorta the chondroitin 6-sulfate/
choridroitin 4rsulfate ratio increases from l in the aortic
arch to nearly 2 in both the following segments (tab. 5),
whereas in the older aorta this ratio decreases from
about 2 in the aortic arch to less than l in segment B
and to l in segment C. in the same direction from proxi-
mal to distal in the older aorta there is a decrease in the
proportion of chondroitin 6-sulfate, whereas in the
yoünger aorta chondroitin 6-sulfate remains nearly con-
stant in all three segments. On ageing the relative propor-
tion of chondroitin 6-sulfate increases in the aortic arch,
but decreases in both the other segments. The propor-
tion of chondroitin 4-sulfate does not seem to change in
the bifurcatio, but it increases in segment B and decreases
in the aortic arch.
Dermatan sulfate does not exhibit significant changes
with age in the total aorta, äs also reported by Toledo
&Mourao (9). In the region of the bifurcatio, however,
where most of the rnineral residues and possibly most
J. Clin. Chem. Clin. Biochem. /Vol. 20,1982 / No, 10
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of the atherosclerotic lesions are located, we detected
a significant increase in the proportion of dermatan
sulfate. Interactions between plasma LDLand VLDL
and extracellular proteochondroitin-dermatan sulfate
(29), which was also shown to induce a moderate release
of lipoprotein lipase in human aorta (30), has been
implicated in the trapping of these lipoproteins in the
aortic arterial wall and in the subsequent development
of atherosclerotic lesions. This hypothesis has been sup-
ported by the Isolation of intact lipoprotein-glycosamino-
glycan complexes from human atherosclerotic lesions
(31) äs well äs from lesions from experimeiital animals
(32). Recently Salisbury & Wagner (33) found in human
aortae a high molecular weight proteoglycan population
which was free of dermatan sulfate and cäpable of asso-
ciations with hyaluronate, and a second proteoglycan
population of lower molecular weight and high dermatan
sulfate content which did not aggregate with hyaluronate.
From bovine aortae Kapoor et al. (34) isolated 3 proteo-
glycan populations, one of which contairiing only
chondroitin 6.-sulfate chains, the other two being proteo^
dermatan Sulfates of different composition. It is tempt-
ing to speculate from our results that with increasing
age the proportion of the aortic proteoglycans in seg-
ment C (tab. 5) might change, in the sense that the
chondroitin 6-sulfate-containing proteoglycan popula-
tion cäpable of forming aggregates with hyaluronate is
partly substituted by dermatan sulfate-containing proteo-
glycans, whereby the possibility of complexing with
plasma LDL and VLDL might increase.
The possible uptake of plasma LDL and VLDL com-
plexing with extracellular aortic proteoglycans might be
supported by our finding that the proportion of heparan
sulfate decreases significantly in segment C on ageing
(tab. 5). This could mean a loss in the protective func^
tion of the heparan sulfate at the endothelial surface
and may thereby facilitate the trapping of the lipopro-
teins by extracellular intimal proteoglycans.
From the distribution of hyaluronate and keratan sulfate
further perspectives can be derived. The proportion of
hyaluronate is decreased with age in the aortic arch and
increased strongly in the bifurcatio aortae. With respect
to the formation of aortic proteoglycan aggregates, the
existence of which and their similarity to those of
cartilage have been demonstrated by several groups
(33, 35, 36, 37), the behaviör of the hyaluronate con-
centration on ageing could suggest a decrease in the
aortic arch and an increase in the bifurcatio aortae. An
increase in hyaluronate does not necessarily mean an
increase in aggregation, since aortic proteoglycans seem
to exhibit a particularly low aggregation rate (33). There-
fore, it might even be possible, that the hyaluronate con-
tent increases äs a sort of compensatory effect for losses
in e.g. waterjbinding etc, while the content of proteo-
glycan aggregates decreases.
The relative proportion, but also the concentration of
keratan sulfate, which was for the first time isolated and
charäcterized by us several years ago (10—12), exhibit
an increase from proximal to distal (from segnient A to
C) and also in eachsegment on ageing.Montanist al.
(17) reported an increase öf keratan sulfate in the
abdominal aorta, but iio change in the aortic arch. How-
ever, the methods employed by these authors, especially
to determine keratan sulfate, did not seem to be suit-
able for obtaining exact results. Increasing eoncentra-
tions and relative proportions of keratan sulfate might
point to an mcrease of the so^called keratan sulfaterrich
region in the aortic protepglycans, thougji the presence
of keratan sulfate in aortic proteoglycans together with
chondroitin Sulfates has not yet been shöwn. But, since
their similarity tö cartilaginous proteoglycans was demon-
strated (33, 35, 36, 37), it seems plausible to ask if the
changing composition of the aortic proteogiycans with
age resembles that of the cartilaginous proteoglycans on
ageing. Inerot et al. (38) were able to demonstrate that
the relative proportion of keratan sulfate increases with
a corresponding decrease in the proportion of the chon^
droitin Sulfates in old hip cartilage, this being a reason
for the decreasing elasticity with age. As the elästicity öf
the older aorta deereäses, it seems obvioüs that the com-
position of the aortic proteoglycan might be ohanged in
an analogous manner: the keratan sulfate content
increases at the expense of the chondroitin 6-sulfate or
chondröitin 4-sulfäte content (see table 5).
Since the increasing deposition of calcium phosphate in
each aortic segment correlates with the increasing con^
centration and relative proportion of keratan sulfate,
both spatially in moving from the aortic arch to the bi-
furcatio aortae, arid with age, a sört of nucleäting func-
tion may ailso be cönsidered for keratan sulfate. As ion
exchanging macromolecuies the gjycosamihoglycans
exhibit different affinities to Ca2+ (39) which is high in
chondroitin Sulfates, especially chondroitin 6-sulfate,
and lowest in keratan sulfate. A decrease in chondroitin
sulfate content of the aortic pröteöglycähs iii fäypür of
keratan sulfate, which binds Ca2"1" to a much lesser
exterit, would increase the portion of de^ünmobilized
Ca2+, which may give rise to insoluble calcium phos-
phate. Such a micro-precipitate could then sefve.as ä
crystallization nucleus.
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